Brazil’s CADE fines Eli Lilly for sham litigation

Drug company Eli Lilly was fined US$8.4 million on 24 June by Brazil’s competition authority CADE for filing sham lawsuits to prolong its monopoly over a cancer drug.

Get unlimited access to all Latin Lawyer content